Stockscreener 앱 받기
4.985
6.06%
0.285
전일 마감가:
$4.70
열려 있는:
$4.67
하루 거래량:
39,225
Relative Volume:
0.38
시가총액:
$15.98M
수익:
-
순이익/손실:
$-37.68M
주가수익비율:
-0.4212
EPS:
-11.8364
순현금흐름:
$-30.65M
1주 성능:
+2.15%
1개월 성능:
-11.30%
6개월 성능:
-72.37%
1년 성능:
+1,051%
1일 변동 폭
$4.60
$5.06
1주일 범위
$4.42
$5.06
52주 변동 폭
$0.3502
$20.00
Passage Bio Inc Stock (PASG) Company Profile
명칭
Passage Bio Inc
전화
(267) 866-0312
주소
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Compare PASG vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
4.975 | 15.04M | 0 | -37.68M | -30.65M | -11.84 |
VRTX
Vertex Pharmaceuticals Inc
|
524.54 | 134.02B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
672.59 | 68.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
920.31 | 58.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.12 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
191.85 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-21 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2026-04-21 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2026-04-21 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2026-03-31 | 개시 | Oppenheimer | Outperform |
| 2026-02-10 | 재개 | Chardan Capital Markets | Buy |
| 2024-11-29 | 재개 | Wedbush | Outperform |
| 2024-09-03 | 개시 | Rodman & Renshaw | Buy |
| 2022-03-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-01-19 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-07-01 | 개시 | Raymond James | Outperform |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-03-04 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-02-04 | 개시 | Guggenheim | Buy |
| 2021-01-25 | 개시 | Wedbush | Outperform |
| 2021-01-04 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-12-11 | 개시 | Citigroup | Neutral |
| 2020-08-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-06-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-25 | 개시 | Chardan Capital Markets | Buy |
| 2020-03-24 | 개시 | Cowen | Outperform |
| 2020-03-24 | 개시 | Goldman | Buy |
| 2020-03-24 | 개시 | JP Morgan | Overweight |
모두보기
Passage Bio Inc 주식(PASG)의 최신 뉴스
Lynx1 Capital Management LP Increases Stake in Passage Bio Inc - GuruFocus
Passage Bio explores gene therapy potential as investors weigh long-term prospects - AD HOC NEWS
Lynx1 Capital Management Discloses Investment at Passage BIO with 21.0% Stake - TradingView
Passage Bio (PASG) Slides 6% as Shares Test Key Support Near $4.35AD Line Divergence - dars.gov.et
PASGPassage Bio Inc Latest SEC Filings - Finviz
Latham & Watkins Advises Remix Therapeutics in Merger With Passage Bio - Legal Desire Media and Insights
Passage Bio (PASG) holder adds 50,055 shares in open-market buy - Stock Titan
Passage Bio to Merge With Remix in Deal Backed by $100 Million Financing - MyChesCo
Passage Bio, Inc. Actuals & Estimates (NASDAQ:PASG) - TradingView
Enterprise value to EBIT forward of Passage Bio, Inc. – NASDAQ:PASG - TradingView
Layoff Tracker: Biogen axes ‘small number’ of Apellis roles after $5.6B buy - BioSpace
Price to sales forward of Passage Bio, Inc. – NASDAQ:PASG - TradingView
Price to book forward of Passage Bio, Inc. – NASDAQ:PASG - TradingView
Price to earnings forward of Passage Bio, Inc. – NASDAQ:PASG - TradingView
Passage Bio, Inc. Actuals & Estimates (BOATS:PASG) - TradingView
Baselake Partners (PASG) reports 235,058 shares, 7.3% ownership - Stock Titan
Remix Therapeutics secures $100M and a reverse merger - The Business Journals
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Remix to go public in reverse merger with once high-flying Passage Bio - BioPharma Dive
PASG Forecast — Price Target — Prediction for 2027 - TradingView
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Remix to enter Nasdaq through Passage Bio reverse merger - The Pharma Letter
Passage Bio and Remix Therapeutics Announce Merger to Advance RNA-Targeted Cancer Therapies with $100M Financing – Minichart - Minichart
SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today - TradingView
SGMOQ Stock Price and Chart — OTC:SGMOQ - TradingView
PASG Stock Slumps 16% After-Hours — What’s Driving The Selloff? - Asianet Newsable
Stocks to Watch: Micron, ARS Pharmaceuticals, MillerKnoll, Passage Bio - Moomoo
Passage Bio Shares Slide on Merger With Remix Therapeutics - Moomoo
Passage Bio And Remix Therapeutics Announce Merger Agreement - TradingView
Passage Bio (PASG) Slides 3.9% as Momentum Falters Near Key SupportWave Truncation - dars.gov.et
Spurned by the FDA, Passage Bio finds an exit through Remix - Fierce Biotech
Passage Bio (PASG) to merge with Remix; Remix private placement tops $100M - Stock Titan
Passage Bio to merge with Remix Therapeutics in all-stock deal - Investing.com
9 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Passage Bio to Merge With Remix Therapeutics; Remix Valued at $226M, $100M Financing - TradingView
Passage Bio (PASG) to combine with Remix; Remix valued at $226M, $100M raise - Stock Titan
Passage Bio | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactionsmoomoo - Moomoo
Remix Therapeutics to reverse-merge with Passage Bio (PASG) and raise $100M - Stock Titan
Passage Bio and Remix Therapeutics Announce Merger Agreement - GlobeNewswire
PASG Stock Slumps 16% After-HoursWhat's Driving The Selloff? - Menafn
Remix Therapeutics, Inc. entered into a definitive merger agreement to acquire Passage Bio, Inc. in a reverse merger transaction for approximately $230 million. - marketscreener.com
Passage Bio Inc (PASG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Passage Bio Inc (PASG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Passage Bio Inc (PASG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Passage Bio Inc (PASG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Passage Bio Inc (PASG) Institutional Confidence - TradingKey
Passage Bio Inc (PASG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Passage Bio Inc (PASG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Passage Bio Inc (PASG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Passage Bio Inc (PASG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sea Limited’s Shopee Order Growth Reinforces E-Commerce MomentumEarnings Momentum Score - newsline.com
Passage Bio Inc (PASG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Passage Bio Inc 주식 (PASG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Chou William | PRESIDENT AND CEO |
Jan 08 '26 |
Sale |
18.44 |
4,076 |
75,159 |
6,524 |
| Borthwick Kathleen | CFO |
Jan 08 '26 |
Sale |
18.44 |
2,062 |
38,022 |
5,402 |
1.67%
3.59%
자본화:
|
볼륨(24시간):